The rise of copyright’s blockbuster initially fueled a boom for major pharmaceutical companies, however recent developments present a murky picture for those considering a stake. Off-patent alternatives are eating into profits, and continued patent challenges add additional complexity to the click here landscape. While specific companies may stil